Cell and Gene Therapy 2021

While some developers are implementing lessons learned - and launching - their 2nd C and GTs to market, the majority are hoping the launch strategy for their 1st holds strong, as they navigate through a meteor shower of risky unknowns, firsts, new partnerships, and complexities the average pharma team has never experienced before.